Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 1043-1054

  Terán Ventura, Evangelina ^a   Aguilera, Mònica ^a   Vergara, Patri ^a,b   Martínez, Vicente ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Bacterial adherence; FISH; Gut commensal microbiota; Gut inflammation; Host bacterial interactions; Inflammatory bowel disease; TLR; Toll like receptors

Indexed keywords

DNA 16S; INDOMETACIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIUM ADHERENCE; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; COMMENSAL; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; ENTEROBACTERIACEAE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC POLYMORPHISM; HOST PATHOGEN INTERACTION; INFLAMMATION; INTESTINE FLORA; INTESTINE WALL; LACTOBACILLUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; UPREGULATION; ADULT; CECUM; COLON; DNA POLYMORPHISM; DYSBIOSIS; HISTOPATHOLOGY; ILEUM; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BACTERIAL ADHESION; DISEASE MODELS, ANIMAL; INDOMETHACIN; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICROBIOTA; RATS; RATS, SPRAGUE-DAWLEY; TOLL-LIKE RECEPTORS;

EID: 84906792093     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.02.001     Document Type: Article

References (53)

1. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
2. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010, 10:159-169.
3. Eri R., Chieppa M. Messages from the Inside. The Dynamic Environment that Favors Intestinal Homeostasis. Front Immunol 2013, 4:323.
4. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
5. Taurog J.D., Richardson J.A., Croft J.T., Simmons W.A., Zhou M., Fernández-Sueiro J.L., et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994, 180:2359-2364.
6. Xu D., Gao J., Gillilland M., Wu X., Song I., Kao J.Y., et al. Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats. Gastroenterology 2014, 146:484-496.
7. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill H.S., McGuirk P, van Eden W, et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006, 3:275-284.
8. Magrone T., Jirillo E. The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 2013, 19:1329-1342.
9. Dalby A.B., Frank D.N., St Amand A.L., Bendele A.M., Pace N.R. Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota. Appl Environ Microbiol 2006, 72:6707-6715.
10. Porras M., Martín M.T., Soler M., Vergara P. Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis. Am J Physiol Gastrointest Liver Physiol 2004, 287:G58-G64.
11. Silva M.A., Jury J., Porras M., Vergara P., Perdue M.H. Intestinal epithelial barrier dysfunction and dendritic cell redistribution during early stages of inflammation in the rat: role for TLR-2 and-4 blockage. Inflamm Bowel Dis 2008, 14:632-644.
12. Fukata M., Shang L., Santaolalla R., Sotolongo J., Pastorini C., España C., et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis 2011, 17:1464-1473.
13. Terán-Ventura E., Roca M., Martin M.T., Abarca M.L., Martinez V., Vergara P. Characterization of Housing-Related Spontaneous Variations of Gut Microbiota and Expression of Toll Like Receptors 2 and 4 in Rats. Microb Ecol 2010, 60:691-702.
14. Aguilera M., Vergara P., Martínez V. Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterol Motil 2013, 25:e515-e529.
15. Aguilera M., Vergara P., Martínez V. Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats. Microb Ecol 2013, 66:232-243.
16. Amann R.I., Binder B.J., Olson R.J., Chisholm S.W., Devereux R., Stahl D.A. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990, 56:919-1925.
17. Salzman N.H., de Jong H., Paterson Y., Harmsen H.J., Welling G.W., Bos N.A. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002, 148:3651-3660.
18. Ootsubo M, Shimizu T, Tanaka R, Sawabe T, Tajima K, Yoshimizu M, et al. Oligonucleotide probe for detecting Enterobacteriaceae by in situ hybridization. J Appl Microbiol 2002, 93:60-68.
19. Vaahtovuo J., Korkeamaki M., Munukka E., Viljanen M.K., Toivanen P. Quantification of bacteria in human feces using 16S rRNA-hybridization, DNA-staining and flow cytometry. J Microbiol Methods 2005, 63:276-286.
20. Hojberg O., Canibe N., Poulsen H.D., Hedemann M.S., Jensen B.B. Influence of dietary zinc oxide and copper sulfate on the gastrointestinal ecosystem in newly weaned piglets. Appl Environ Microbiol 2005, 71:2267-2277.
21. Kitts C.L. Terminal restriction fragment patterns: a tool for comparing microbial communities and assessing community dynamics. Curr Issues Intest Microbiol 2001, 2:17-25.
22. García-Lafuente A, Antolín M, Guarner F, Crespo E, Salas A, Forcada P, et al. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997, 272:G10-G15.
23. Zoetendal E.G., Mackie R.I. Molecular methods in microbial ecology. Probiotics and prebiotics: Scientific aspects 2005, 1-24. Caister Academic Press, University of Otago, Dunedin, New Zealand. 1st ed. G.W. Tannock (Ed.).
24. Barada K.A., Mourad F.H., Sawah S.I., Khoury C., Safieh-Garabedian B., Nassar C.F., et al. Localized colonic inflammation increases cytokine levels in distant small intestinal segments in the rat. Life Sci 2006, 79:2032-2042.
25. Jacobson K., McHugh K., Collins S.M. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995, 109:718-722.
26. De Schepper H.U., De Man J.G., Moreels T.G., Pelckmans P.A., De Winter B.Y. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease-clinical relevance and pathophysiological mechanisms. Aliment Pharmacol Ther 2008, 27:621-637.
27. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134:577-594.
28. DiBaise J.K., Zhang H., Crowell M.D., Krajmalnik-Brown R., Decker G.A., Rittmann B.E. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008, 83:460-469.
29. Tanigawa T., Watanabe T., Otani K., Nadatani Y., Ohkawa F., Sogawa M., et al. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5. Eur J Pharmacol 2013, 704:64-69.
30. Imaeda H., Fujimoto T., Takahashi K., Kasumi E., Fujiyama Y., Andoh A. Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice. Digestion 2012, 86:250-257.
31. Watanabe T., Nishio H., Tanigawa T., et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol 2009, 297:G506-G513.
32. Robert A., Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 1977, 14:333-341.
33. Weissenborn U., Maedge S., Buettner D., Sewing K.F. Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology 1985, 30:32-39.
34. Satoh H., Guth P.H., Grossman M.I. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 1983, 84:483-489.
35. Mersereau W.A., Hinchey E.J. Neomycin prevents indomethacin-induced gastric peristalsis and mucosal injury in the rat. Can J Physiol Pharmacol 1989, 67:1029-1032.
36. Uejima M., Kinouchi T., Kataoka K., Hiraoka I., Ohnishi Y. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol Immunol 1996, 40:553-560.
37. Michail S., Durbin M., Turner D., Griffiths A.M., Mack D.R., Hyams J., et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2012, 18:1799-1808.
38. Nemoto H., Kataoka K., Ishikawa H., Ikata K., Arimochi H., Iwasaki T., et al. Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci 2012, 57:2955-2964.
39. Larmonier C.B., Laubitz D., Hill F.M., Shehab K.W., Lipinski L., Midura-Kiela M.T., et al. Reduced colonic microbial diversity is associated with colitis in NHE3-deficient mice. Am J Physiol 2013, 305:G667-G677.
40. Heimesaat M.M., Bereswill S., Fischer A., Fuchs D., Struck D., Niebergall J., et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. Immunology 2006, 177:8785-8795.
41. Heimesaat M.M., Fischer A., Siegmund B., Kupz A., Niebergall J., Fuchs D., et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2007, 2:e662.
42. Onderdonk A.B., Richardson J.A., Hammer R.E., Taurog J.D. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 1998, 66:6022-6023.
43. Rath H.C., Schultz M., Freitag R., Dieleman L.A., Li F., Linde H.J., et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001, 69:2277-2285.
44. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
45. Van den Abbeele P., Van de Wiele T., Verstraete W., Possemiers S. The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept. FEMS Microbiol Rev 2011, 35:681-704.
46. Salzman N.H. Microbiota-immune system interaction: an uneasy alliance. Curr Opin Microbiol 2011, 14:99-105.
47. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
48. Buchholz B.M., Bauer A.J. Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis. Neurogastroenterol Motil 2010, 22:232-245.
49. Erridge C., Duncan S.H., Bereswill S., Heimesaat M.M. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 2010, 5:e9125.
50. Watanabe T., Higuchi K., Kobata A., Nishio H., Tanigawa T., Shiba M., et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008, 57:181-187.
51. Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2008, 2:193-196.
52. Frolova L., Drastich P., Rossmann P., Klimesova K., Tlaskalova-Hogenova H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem 2008, 56:267-274.
53. Szebeni B., Veres G., Dezsõfi A., Rusai K., Vannay A., Mraz M., et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 2008, 151:34-41.